178 related articles for article (PubMed ID: 36018314)
1. Serologic phenotypes distinguish systemic lupus erythematosus patients developing interstitial lung disease and/or myositis.
Cotton T; Fritzler MJ; Choi MY; Zheng B; Niaki OZ; Pineau CA; Lukusa L; Bernatsky S
Lupus; 2022 Oct; 31(12):1477-1484. PubMed ID: 36018314
[TBL] [Abstract][Full Text] [Related]
2. Myositis in systemic lupus erythematosus.
Cotton T; Niaki OZ; Zheng B; Pineau CA; Fritzler M; Vinet E; Clarke AE; Bernatsky S
Lupus; 2021 Apr; 30(4):615-619. PubMed ID: 33461416
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of interstitial lung disease in systemic lupus erythematosus in France: A nation-wide population-based study over 10 years.
Mageau A; Borie R; Crestani B; Timsit JF; Papo T; Sacre K
Respirology; 2022 Aug; 27(8):630-634. PubMed ID: 35446457
[TBL] [Abstract][Full Text] [Related]
4. Two clusters of systemic lupus erythematosus patients with muscle involvement in a Chinese cohort.
Zhao L; Huang W; Wang H; Chen J; Zhang D; Wang X; Sun F; Ye S
Int J Rheum Dis; 2023 Jan; 26(1):51-59. PubMed ID: 36117395
[TBL] [Abstract][Full Text] [Related]
5. Investigating the potential associated factors and developing a risk model for interstitial lung disease in Chinese patients with systemic lupus erythematosus.
Liu Y; Lu F; Liao H; Wang L; Lu P
Lupus; 2023 Jul; 32(8):993-1000. PubMed ID: 37338524
[TBL] [Abstract][Full Text] [Related]
6. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
[TBL] [Abstract][Full Text] [Related]
7. Interstitial lung disease in patients with systemic lupus erythematosus: a cohort study.
Şenkal N; Kıyan E; Demir AA; Yalçınkaya Y; Gül A; İnanç M; Öçal ML; Esen BA
Turk J Med Sci; 2022 Feb; 52(1):76-82. PubMed ID: 36161596
[TBL] [Abstract][Full Text] [Related]
8. Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis.
Vojinovic T; Cavazzana I; Ceruti P; Fredi M; Modina D; Berlendis M; Franceschini F
Clin Rev Allergy Immunol; 2021 Feb; 60(1):87-94. PubMed ID: 33141387
[TBL] [Abstract][Full Text] [Related]
9. Interstitial Lung Disease in Systemic Lupus Erythematosus and Systemic Sclerosis: How Can We Manage the Challenge?
Richter P; Cardoneanu A; Dima N; Bratoiu I; Rezus C; Burlui AM; Costin D; Macovei LA; Rezus E
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298342
[TBL] [Abstract][Full Text] [Related]
10. Risk of interstitial lung disease in patients with newly diagnosed systemic autoimmune rheumatic disease: A nationwide, population-based cohort study.
Ng KH; Chen DY; Lin CH; Chao WC; Chen YM; Chen YH; Huang WN; Hsieh TY; Lai KL; Tang KT; Chen HH
Semin Arthritis Rheum; 2020 Oct; 50(5):840-845. PubMed ID: 32896697
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics and related factors of systemic lupus erythematosus with interstitial pneumonia].
Xia FF; Lu FA; Lv HM; Yang GA; Liu Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 53(2):266-272. PubMed ID: 33879896
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of serum Krebs von den Lungen-6 for the management of myositis-associated interstitial lung disease.
Takanashi S; Nishina N; Nakazawa M; Kaneko Y; Takeuchi T
Rheumatology (Oxford); 2019 Jun; 58(6):1034-1039. PubMed ID: 30624752
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay.
Jee AS; Parker MJS; Bleasel JF; Troy LK; Lau EM; Jo HE; Teoh AKY; Webster S; Adelstein S; Corte TJ
Respir Med; 2021 Oct; 187():106581. PubMed ID: 34454312
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary manifestations in late versus early systemic lupus erythematosus: A systematic review and meta-analysis.
Medlin JL; Hansen KE; McCoy SS; Bartels CM
Semin Arthritis Rheum; 2018 Oct; 48(2):198-204. PubMed ID: 29550111
[TBL] [Abstract][Full Text] [Related]
15. Serological risk factors for concomitant interstitial lung disease in patients with idiopathic inflammatory myopathy.
Huang HL; Lin WC; Yeh CC; Sun YT
J Clin Neurosci; 2020 Apr; 74():32-35. PubMed ID: 31982271
[TBL] [Abstract][Full Text] [Related]
16. Brief Report: How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria.
Mosca M; Costenbader KH; Johnson SR; Lorenzoni V; Sebastiani GD; Hoyer BF; Navarra S; Bonfa E; Ramsey-Goldman R; Medina-Rosas J; Piga M; Tani C; Tedeschi SK; Dörner T; Aringer M; Touma Z
Arthritis Rheumatol; 2019 Jan; 71(1):91-98. PubMed ID: 30035365
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease.
Rigolet A; Musset L; Dubourg O; Maisonobe T; Grenier P; Charuel JL; Behin A; Herson S; Amoura Z; Benveniste O
Medicine (Baltimore); 2012 Mar; 91(2):95-102. PubMed ID: 22391471
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
Wirestam L; Enocsson H; Skogh T; Padyukov L; Jönsen A; Urowitz MB; Gladman DD; Romero-Diaz J; Bae SC; Fortin PR; Sanchez-Guerrero J; Clarke AE; Bernatsky S; Gordon C; Hanly JG; Wallace D; Isenberg DA; Rahman A; Merrill J; Ginzler E; Alarcón GS; Chatham WW; Petri M; Khamashta M; Aranow C; Mackay M; Dooley MA; Manzi S; Ramsey-Goldman R; Nived O; Steinsson K; Zoma A; Ruiz-Irastorza G; Lim S; Kalunian K; Inanc M; van Vollenhoven R; Ramos-Casals M; Kamen DL; Jacobsen S; Peschken C; Askanase A; Stoll T; Bruce IN; Wetterö J; Sjöwall C
J Rheumatol; 2019 May; 46(5):492-500. PubMed ID: 30647177
[TBL] [Abstract][Full Text] [Related]
19. Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment.
Mimori T; Nakashima R; Hosono Y
Curr Rheumatol Rep; 2012 Jun; 14(3):264-74. PubMed ID: 22367479
[TBL] [Abstract][Full Text] [Related]
20. Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort.
Chen F; Wang J; Zhang P; Zuo Y; Ye L; Wang G; Shu X
Front Immunol; 2022; 13():879266. PubMed ID: 35603153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]